Does GEMCITABINE Cause Diffuse large b-cell lymphoma recurrent? 280 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 280 reports of Diffuse large b-cell lymphoma recurrent have been filed in association with GEMCITABINE (Gemcitabine). This represents 0.9% of all adverse event reports for GEMCITABINE.
280
Reports of Diffuse large b-cell lymphoma recurrent with GEMCITABINE
0.9%
of all GEMCITABINE reports
22
Deaths
35
Hospitalizations
How Dangerous Is Diffuse large b-cell lymphoma recurrent From GEMCITABINE?
Of the 280 reports, 22 (7.9%) resulted in death, 35 (12.5%) required hospitalization, and 12 (4.3%) were considered life-threatening.
Is Diffuse large b-cell lymphoma recurrent Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GEMCITABINE. However, 280 reports have been filed with the FAERS database.
What Other Side Effects Does GEMCITABINE Cause?
Off label use (3,319)
Disease progression (3,123)
Thrombocytopenia (2,320)
Drug ineffective (2,003)
Malignant neoplasm progression (1,962)
Neutropenia (1,892)
Anaemia (1,745)
Pyrexia (1,511)
Nausea (1,336)
Myelosuppression (1,197)
What Other Drugs Cause Diffuse large b-cell lymphoma recurrent?
RITUXIMAB (1,359)
CYCLOPHOSPHAMIDE (1,007)
VINCRISTINE (957)
DOXORUBICIN (953)
PREDNISONE (738)
CYTARABINE (406)
DEXAMETHASONE (402)
ETOPOSIDE (375)
CISPLATIN (306)
BENDAMUSTINE (255)
Which GEMCITABINE Alternatives Have Lower Diffuse large b-cell lymphoma recurrent Risk?
GEMCITABINE vs GEMCITABINE\GEMCITABINE
GEMCITABINE vs GEMFIBROZIL
GEMCITABINE vs GEMTUZUMAB OZOGAMICIN
GEMCITABINE vs GEMZAR
GEMCITABINE vs GENTAMICIN